RT Book, Section A1 Mueller, Scott W. A1 Fish, Douglas N. A2 DiPiro, Joseph T. A2 Talbert, Robert L. A2 Yee, Gary C. A2 Matzke, Gary R. A2 Wells, Barbara G. A2 Posey, L. Michael SR Print(0) ID 1153484935 T1 Infections in Immunocompromised Patients T2 Pharmacotherapy: A Pathophysiologic Approach, 10e YR 2017 FD 2017 PB McGraw-Hill Education PP New York, NY SN 9781259587481 LK accesspharmacy.mhmedical.com/content.aspx?aid=1153484935 RD 2023/02/01 AB Content UpdateMay 16, 2018ASCO and IDSA Practice Guideline Update on Outpatient Management of Febrile Neutropenia in Adults with Cancer: An expert panel of the American Society of Clinical Oncology (ASCO) and the Infectious Diseases Society of America (IDSA) conducted a systematic review and provided updated recommendations for outpatient evaluation and treatment of fever and neutropenia in adults treated for malignancy. The guideline was developed to assist healthcare providers in identifying appropriate patient candidates for outpatient management of fever and neutropenia based on clinical criteria and validated scoring systems. Clinicians must inform patients about safety practices and patient/caregiver responsibilities after discharge because they have important roles in ensuring the safe and effective outpatient management of febrile neutropenia.